65 related articles for article (PubMed ID: 11060500)
1. Expression of a truncated retroviral envelope gene enhances expression of normal cellular phenotypes.
Chen H; Chung SW; Wong PM
J Biomed Sci; 2000; 7(6):514-22. PubMed ID: 11060500
[TBL] [Abstract][Full Text] [Related]
2. The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.
Haas DL; Lutzko C; Logan AC; Cho GJ; Skelton D; Jin Yu X; Pepper KA; Kohn DB
J Virol; 2003 Sep; 77(17):9439-50. PubMed ID: 12915559
[TBL] [Abstract][Full Text] [Related]
3. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
4. Deletion of a short, untranslated region adjacent to the polypurine tract in Moloney murine leukemia virus leads to formation of aberrant 5' plus-strand DNA ends in vivo.
Bacharach E; Gonsky J; Lim D; Goff SP
J Virol; 2000 May; 74(10):4755-64. PubMed ID: 10775614
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary studies on the design of retroviral vectors for substitutive gene therapy].
Martín F; Jean-Mairet Y; Talavera A
Microbiologia; 1996 Mar; 12(1):43-50. PubMed ID: 9019133
[TBL] [Abstract][Full Text] [Related]
6. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.
Liu L; Anderson WF; Beart RW; Gordon EM; Hall FL
J Virol; 2000 Jun; 74(11):5320-8. PubMed ID: 10799609
[TBL] [Abstract][Full Text] [Related]
9. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.
Li KJ; Garoff H
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192
[TBL] [Abstract][Full Text] [Related]
10. Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.
Seamon JA; Jones KS; Miller C; Roth MJ
J Virol; 2002 Aug; 76(16):8475-84. PubMed ID: 12134052
[TBL] [Abstract][Full Text] [Related]
11. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein.
Rothenberg SM; Olsen MN; Laurent LC; Crowley RA; Brown PO
J Virol; 2001 Dec; 75(23):11851-62. PubMed ID: 11689666
[TBL] [Abstract][Full Text] [Related]
13. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
14. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
15. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
[TBL] [Abstract][Full Text] [Related]
16. Plasmoviruses: nonviral/viral vectors for gene therapy.
Noguiez-Hellin P; Meur MR; Salzmann JL; Klatzmann D
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4175-80. PubMed ID: 8633036
[TBL] [Abstract][Full Text] [Related]
17. Generation of novel syncytium-inducing and host range variants of ecotropic moloney murine leukemia virus in Mus spicilegus.
Jung YT; Kozak CA
J Virol; 2003 May; 77(9):5065-72. PubMed ID: 12692209
[TBL] [Abstract][Full Text] [Related]
18. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication.
Dang Q; Hu WS
J Virol; 2001 Jan; 75(2):809-20. PubMed ID: 11134294
[TBL] [Abstract][Full Text] [Related]
19. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors.
Masood R; Gordon EM; Whitley MD; Wu BW; Cannon P; Evans L; Anderson WF; Gill P; Hall FL
Int J Mol Med; 2001 Oct; 8(4):335-43. PubMed ID: 11562769
[TBL] [Abstract][Full Text] [Related]
20. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
